Resmed Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
This session, we welcome from ResMed, Rob Douglas, COO; and David Pendarvis, Global legal Counsel from the company. Thank you for your time today, gentlemen. What we'll start with is an introduction from Rob, and then we'll go to Q&A. Please enter your questions in your browser, if you're connected directly, and I'll endeavor to read your questions out.
So with that, thank you for your time today, gentlemen. And Rob, I'll throw to you for some opening remarks.
Great. Thanks, Sean. Thanks for having us here. For everyone listening, we did distribute a brief slide deck with just a few summary statistics on it, if you want to have a look at that and a safe harbor statement.
For those of you who don't know ResMed, we're the world leader in the -- including sleep apnea and other chronic diseases like COPD and asthma. Our focus really is on treatment outside of the hospital and as I'll explain in a second, our
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |